Last reviewed · How we verify
Apitox - pure honeybee toxin
Apitox - pure honeybee toxin is a Natural product immunomodulator Small molecule drug developed by Apimeds, Inc.. It is currently in Phase 3 development for Rheumatoid arthritis, Inflammatory joint disorders. Also known as: Apitoxin.
Apitoxin, the active component of honeybee venom, exerts anti-inflammatory and immunomodulatory effects through phospholipase A2 and other peptide components that modulate immune cell activity and reduce inflammatory mediators.
Apitoxin, the active component of honeybee venom, exerts anti-inflammatory and immunomodulatory effects through phospholipase A2 and other peptide components that modulate immune cell activity and reduce inflammatory mediators. Used for Rheumatoid arthritis, Inflammatory joint disorders.
At a glance
| Generic name | Apitox - pure honeybee toxin |
|---|---|
| Also known as | Apitoxin |
| Sponsor | Apimeds, Inc. |
| Drug class | Natural product immunomodulator |
| Target | Phospholipase A2, melittin, multiple immune cell receptors |
| Modality | Small molecule |
| Therapeutic area | Immunology / Rheumatology |
| Phase | Phase 3 |
Mechanism of action
Honeybee venom contains multiple bioactive peptides, primarily melittin and phospholipase A2, which interact with cell membranes and immune receptors to suppress pro-inflammatory cytokine production and modulate T-cell and macrophage function. The venom's mechanism involves both direct antimicrobial activity and indirect immune regulation, potentially useful in inflammatory and autoimmune conditions. Apitoxin has been studied for its analgesic and anti-arthritic properties in preclinical and early clinical settings.
Approved indications
- Rheumatoid arthritis
- Inflammatory joint disorders
Common side effects
- Local injection site reactions (pain, swelling, erythema)
- Allergic reactions / anaphylaxis risk
- Systemic inflammatory response
Key clinical trials
- Evaluate Safety and Efficacy of Apitox Add-on Therapy for Improving Disability and Quality of Life in MS Patients (PHASE3)
- Apitox, Honeybee Venom Treatment for Osteoarthritis Pain and Inflammation (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Apitox - pure honeybee toxin CI brief — competitive landscape report
- Apitox - pure honeybee toxin updates RSS · CI watch RSS
- Apimeds, Inc. portfolio CI
Frequently asked questions about Apitox - pure honeybee toxin
What is Apitox - pure honeybee toxin?
How does Apitox - pure honeybee toxin work?
What is Apitox - pure honeybee toxin used for?
Who makes Apitox - pure honeybee toxin?
Is Apitox - pure honeybee toxin also known as anything else?
What drug class is Apitox - pure honeybee toxin in?
What development phase is Apitox - pure honeybee toxin in?
What are the side effects of Apitox - pure honeybee toxin?
What does Apitox - pure honeybee toxin target?
Related
- Drug class: All Natural product immunomodulator drugs
- Target: All drugs targeting Phospholipase A2, melittin, multiple immune cell receptors
- Manufacturer: Apimeds, Inc. — full pipeline
- Therapeutic area: All drugs in Immunology / Rheumatology
- Indication: Drugs for Rheumatoid arthritis
- Indication: Drugs for Inflammatory joint disorders
- Also known as: Apitoxin
- Compare: Apitox - pure honeybee toxin vs similar drugs
- Pricing: Apitox - pure honeybee toxin cost, discount & access